% | $
Quotes you view appear here for quick access.

Dendreon Anonim Ortaklik Message Board

  • dinepat203 dinepat203 Jun 25, 2013 4:25 PM Flag

    Buyout ?

    Aragon deal to be in 3rd Quarter and ARN-509—for prostate cancer in Phase 2 development. Final stage to approval might take until 2017. JNJ says “Prostate cancer is one of our main areas of focus.”
    Now, JNJ needs something before patent expiry in 2016.